PRESENTATION & DOSING

DOWNLOAD THE HUMIRA PRESCRIBING GUIDE

Presentation¹

Dosing¹

80 mg pre-filled syringe is also available for balance of supply and maintenance.
*80 mg and 40 mg presentations available for patients with hidradenitis suppurativa (HS) or plaque psoriasis and can be prescribed based on prescriber and patient preference. 80 mg presentation may enhance patient convenience with a reduced injection number vs 40 mg. #Depending on patient preference, the first loading dose may be split into 80 mg on Day 1 and 80 mg on Day 2.  ‡Depending on patient preference, the first loading dose may be split into two 40 mg injections on Day 1 and two 40 mg injections on Day 2. §Dose given as two 40 mg injections on Day 15. ǁUtilise single Pharmaceutical Benefits Scheme (PBS) item codes for adolescent patients.  ¶Beyond 16 weeks, patients with inadequate response may benefit from an increase in dosage to 40 mg every week or 80 mg fortnightly. Response should be periodically evaluated. Please refer to the Product Information for detailed information. Dose escalation after week 16 for inadequate response is not listed on the PBS.